Investing in cannabis stocks is not for the faint of heart. It’s common to see these stocks pop only to retrace their gains quickly.
Understanding the implications and the strategies that institutional investors will use as they enter the sector, currently dominated by retail, could be a generational difference-maker for so many.
This week, we speak with Pablo Zuanic to discuss the following:
- Cannabis Long-Term Investments:
- Navigating Market Nuances
- 280E Removal, Germany implications
- So much more
About Pablo Zuanic
Pablo Zuanic is a well-known and highly rated consumer sector equity analyst, most recently following the cannabis and psychedelics sector. Over the past four years he launched coverage of over 35 companies (MSOs, LPs, CBD, MJ ancillary, mental health clinics), kept close track of sectoral trends, and followed the reform process in the US and elsewhere.
Pablo is the Managing Partner at Zuanic & Associates, a firm that recently launched a curated, comprehensive, thoughtful, data-driven research service on the cannabis and psychedelics sectors aimed to institutional investors and corporations. Pablo and the firm are also available for short term consulting and research advisory projects.
Guest Links
- https://www.linkedin.com/in/pablo-zuanic-21b5a610
- https://zuanicgroup.com/
- https://twitter.com/420odysseus
Follow us: Our Links.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain
The Dime is a top 5% most shared global podcast
The Dime is a top 50 Cannabis Podcast
Sign up for our playbook here:
🎥 YouTube: The Dime
📸 Instagram: The Dime
